Copyright
©The Author(s) 2020.
World J Hepatol. Dec 27, 2020; 12(12): 1182-1197
Published online Dec 27, 2020. doi: 10.4254/wjh.v12.i12.1182
Published online Dec 27, 2020. doi: 10.4254/wjh.v12.i12.1182
Figure 1 Spectrum of medications used in coronavirus disease 2019 likely to cause liver injury.
COVID-19: Coronavirus disease 2019; UDP-GT: UDP-glucuronosyltransferase; NAFLD: Nonalcoholic fatty liver disease.
- Citation: Anirvan P, Bharali P, Gogoi M, Thuluvath PJ, Singh SP, Satapathy SK. Liver injury in COVID-19: The hepatic aspect of the respiratory syndrome — what we know so far. World J Hepatol 2020; 12(12): 1182-1197
- URL: https://www.wjgnet.com/1948-5182/full/v12/i12/1182.htm
- DOI: https://dx.doi.org/10.4254/wjh.v12.i12.1182